[HTML][HTML] Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

…, GT Ferguson, C Jenkins, PW Jones… - … England Journal of …, 2007 - Mass Medical Soc
Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …

The St George's Respiratory Questionnaire.

PW Jones, FH Quirk, CM Baveystock - Respiratory medicine, 1991 - europepmc.org
The St George's Respiratory Questionnaire is a standardized self-completed questionnaire
for measuring impaired health and perceived well-being ('quality of life') in airways disease. It …

Outcomes for COPD pharmacological trials: from lung function to biomarkers

…, PMA Calverley, BR Celli, PW Jones… - European respiratory …, 2008 - Eur Respiratory Soc
The American Thoracic Society/European Respiratory Society jointly created a Task Force
on “Outcomes for COPD pharmacological trials: from lung function to biomarkers” to inform …

Health status measurement in chronic obstructive pulmonary disease

PW Jones - Thorax, 2001 - thorax.bmj.com
Health status measurement is a common feature of studies in chronic obstructive pulmonary
disease (COPD). This review assesses recent evidence for the validity of these …

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE …

PS Burge, PMA Calverley, PW Jones, S Spencer… - Bmj, 2000 - bmj.com
Objectives: To determine the effect of long term inhaled corticosteroids on lung function,
exacerbations, and health status in patients with moderate to severe chronic obstructive …

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

J Vestbo, SS Hurd, AG Agustí, PW Jones… - American journal of …, 2013 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …

Development and first validation of the COPD Assessment Test

PW Jones, G Harding, P Berry, I Wiklund… - European …, 2009 - Eur Respiratory Soc
There is need for a validated short, simple instrument to quantify chronic obstructive
pulmonary disease (COPD) impact in routine practice to aid health status assessment and …

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease

JC Bestall, EA Paul, R Garrod, R Garnham, PW Jones… - Thorax, 1999 - thorax.bmj.com
BACKGROUND Methods of classifying chronic obstructive pulmonary disease (COPD)
depend largely upon spirometric measurements but disability is only weakly related to …

Quasiconformal mappings and extendability of functions in Sobolev spaces

PW Jones - 1981 - projecteuclid.org
Let~ be an open connected domain in R n, n~ 2. If a is a multi-index, a=(ai,~ 2..... a~) EZ~,
the length of a, denoted by [a I, is the integer Xj%~ and D a=(~/~ xl)"...(~/~ x~)~% A locMly …

A self-complete measure of health status for chronic airflow limitation

PW Jones, FH Quirk, CM Baveystock… - Am Rev Respir …, 1992 - atsjournals.org
… The selection of tightly defined patient groups reduced only the interpatient variance in
weights by 1 to 2% (Quirk and Jones, unpublished observations). These findings …